Immunic announces 1-for-10 reverse stock split [Seeking Alpha]
Immunic, Inc. (IMUX)
Company Research
Source: Seeking Alpha
The reverse stock split is primarily intended to allow Immunic to meet its contractual obligations under the securities purchase agreement entered into between the company and certain institutional and accredited investors on February 12, 2026. IMUX premarket to $0.8602. Source: Press Release Fresh Stock Ideas, Every Day More on Immunic Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow Immunic garners new Buy at Guggenheim on lead asset Immunic rises after $400M private placement, leadership transition Seeking Alpha's Quant Rating on Immunic Historical earnings data for Immunic
Show less
Read more
Impact Snapshot
Event Time:
IMUX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMUX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMUX alerts
High impacting Immunic, Inc. news events
Weekly update
A roundup of the hottest topics
IMUX
News
- Immunic appoints Michael Panzara as CMO ahead of pivotal MS drug readout [Yahoo! Finance]Yahoo! Finance
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer [TheStreet.com]TheStreet.com
- Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical OfficerPR Newswire
- Immunic to implement 1-for-10 reverse stock split [Yahoo! Finance]Yahoo! Finance
IMUX
Earnings
- 11/13/25 - Beat
IMUX
Sec Filings
- 4/29/26 - Form 4
- 4/29/26 - Form 3
- 4/28/26 - Form 8-K
- IMUX's page on the SEC website